Topamax 200 mg Filmtabletten Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

topamax 200 mg filmtabletten

janssen-cilag ag - topiramatum - filmtabletten - topiramatum 200 mg, lactosum monohydricum 43.5 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium < 23 mg, amylum pregelificatum, magnesii stearas, Überzug: hypromellosum, macrogola, polysorbatum 80, e 171, e 172 (rubrum), cera carnauba pro compresso obducto. - antiepileptikum, migräneprophylaxe - synthetika

Durogesic Matrix 25 ug/h Transdermales Pflaster Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

durogesic matrix 25 ug/h transdermales pflaster

janssen-cilag ag - fentanylum - transdermales pflaster - fentanylum 4.2 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: rot, ad praeparationem pro 10.5 cm² cum liberatione 25 µg/h. - analgetikum - synthetika

Durogesic Matrix 50 ug/h Transdermales Pflaster Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

durogesic matrix 50 ug/h transdermales pflaster

janssen-cilag ag - fentanylum - transdermales pflaster - fentanylum 8.4 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: grün, ad praeparationem pro 21 cm² cum liberatione 50 µg/h. - analgetikum - synthetika

Durogesic Matrix 75 ug/h Transdermales Pflaster Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

durogesic matrix 75 ug/h transdermales pflaster

janssen-cilag ag - fentanylum - transdermales pflaster - fentanylum 12.6 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: blau, ad praeparationem pro 31.5 cm² cum liberatione 75 µg/h. - analgetikum - synthetika

Durogesic Matrix 100 ug/h Transdermales Pflaster Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

durogesic matrix 100 ug/h transdermales pflaster

janssen-cilag ag - fentanylum - transdermales pflaster - fentanylum 16.8 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: grau, ad praeparationem pro 42 cm² cum liberatione 100 µg/h. - analgetikum - synthetika

Durogesic Matrix 12 ug/h Transdermales Pflaster Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

durogesic matrix 12 ug/h transdermales pflaster

janssen-cilag ag - fentanylum - transdermales pflaster - fentanylum 2.1 mg, acrylates et vinylis acetatis polymerisatum, trägermaterial: polyesterum, ethyleni et vinylis acetatis polymerisatum, drucktinte: orange, ad praeparationem pro 5.25 cm² cum liberatione 12.5 µg/h. - analgetikum - synthetika

Topamax 15 mg Kapseln Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

topamax 15 mg kapseln

janssen-cilag ag - topiramatum - kapseln - topiramatum 15 mg, sacchari sphaerae, povidonum k 30, cellulosi acetas, kapselhülle: gelatina, e 171 pro capsula. - antiepileptikum, migräneprophylaxe - synthetika

Topamax 50 mg Kapseln Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

topamax 50 mg kapseln

janssen-cilag ag - topiramatum - kapseln - topiramatum 50 mg, sacchari sphaerae, povidonum k 30, cellulosi acetas, kapselhülle: gelatina, e 171 pro capsula. - antiepileptikum, migräneprophylaxe - synthetika

Concerta 18 mg Retardtabletten Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

concerta 18 mg retardtabletten

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 7.08 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 6.5 mg, hypromellosum, e 171, triacetinum, e 172 (flavum), acidum stearicum, macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - zentral wirkendes sympathomimetikum - synthetika

Concerta 36 mg Retardtabletten Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

concerta 36 mg retardtabletten

janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 14.16 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 16.7 mg, hypromellosum, e 171, triacetinum, macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - zentral wirkendes sympathomimetikum - synthetika